This indicator shows the number and percent of people with diabetes receiving any hypoglycaemic medication regularly. Regular use was defined as hypoglycaemic medication dispensed in three or more quarters in a year
Analysing variation in hypoglycaemic medication usage can offer insights into several aspects of diabetes management, including health care access and quality, provider practices, patient preferences, health literacy, adherence and tolerability. This information is valuable for designing targeted interventions to improve diabetes care and reduce disparities in health care delivery.
People with diabetes dispensed any hypoglycaemic medication in three or four quarters in the relevant year
Numerator detail
Medications: 179401 & 179402 metformin hydrochloride
124701 & 124702 acarbose
414925 dulaglutide
413725 & 413726 empagliflozin
413825, 413826, 413827 & 413828 empagliflozin with metformin hydrochloride
156702 glibenclamide
156801 gliclazide
156901 glipizide
119201 & 119202 insulin lispro
164801 & 164803 insulin neutral
164903 & 164904 insulin isophane
165502 inj crystalline human 100 u per ml
165501 inj human 100 u per ml
378325, 378326 & 378327 insulin aspart
385725, 385726 & 385727 insulin glargine
388225 & 388226 insulin lispro with insulin lispro protamine
390825, 390826 & 390827 insulin glulisine
398227 insulin aspart with insulin aspart protamine
630002 & 630003 insulin isophane with insulin neutral
380025, 380026 & 380027 pioglitazone
410325 vildagliptin
410425 & 410426 vildagliptin with metformin hydrochloride
Count of distinct master NHIs identified as having diabetes as per the VDR.
Disaggregation
For single map analysis: By year (2018‒22), age group (0‒14 years, 15‒24 years, 25‒44 years, 45‒64 years, 65‒74 years and 75+ years), gender (female and male), ethnic group (Māori, Pacific peoples, Indian and European/other) and Health New Zealand district of domicile.
For PHO analysis: By year (2022), age group (0‒14 years, 15‒24 years, 25‒44 years, 45‒64 years, 65‒74 years and 75+ years), gender (female and male), ethnic group (Māori, Pacific peoples, Indian and European/other), PHO most recently enrolled with (for the relevant year), PHO group (small, medium, medium‒large and large).
- Data is not presented where the number of people in the numerator was less than 10. This is to preserve confidentiality.
- Ethnicity data presented is prioritised ethnic group (Māori, Pacific peoples, Indian and European/other).
- For all indicators, individuals with missing values for any of the variables of interest (age, gender, ethnicity and district) are excluded completely. For instance, if there are any missing values for age, they are excluded from all analyses. This approach ensures a consistent denominator throughout the analyses.
- Demographic information is taken from the VDR.
Exclusions
- People who died during the year
- People not enrolled in a PHO